RadHint

Calculators

Every score and calculator, A–Z. Each is interactive, cites its source, and links back to the workflows that use it.

AAA surveillance interval

SVS 2018

Surveillance interval for an infrarenal abdominal aortic aneurysm by maximum outer-to-outer diameter.

Complete the inputs to see the result.

Source: SVS practice guidelines on AAA — Chaikof EL et al. J Vasc Surg (2018)

Used in: Abdominal aortic aneurysm — US / CT

ACR TI-RADS

ACR TI-RADS 2017

Point-based ultrasound risk stratification of a thyroid nodule.

Composition
Echogenicity
Shape
Margin
Echogenic foci (add all that apply)

Complete the inputs to see the result.

Source: ACR TI-RADS white paper — Tessler FN et al. J Am Coll Radiol (2017); ACR TI-RADS — American College of Radiology (2017)

Used in: Thyroid nodule — Ultrasound (ACR TI-RADS)

Adrenal chemical-shift signal index

Signal intensity index for a lipid-rich adenoma on in-/opposed-phase MRI.

Complete the inputs to see the result.

Signal intensity index = (in-phase − opposed-phase) / in-phase × 100. A drop ≥ 16.5% at 1.5 T indicates a lipid-rich adenoma. Note: clear-cell RCC and HCC metastases can also drop signal; the spleen is an unreliable internal reference in iron overload (use kidney).

Source: Chemical-shift adrenal MRI — Fujiyoshi F et al. AJR (2003)

Used in: Adrenal incidentaloma — CT / MRI

Adrenal CT washout

ACR incidental adrenal mass (2017)

Absolute and relative washout to characterize a homogeneous adrenal mass.

Complete the inputs to see the result.

Absolute washout (APW) = (enhanced − delayed) / (enhanced − unenhanced) × 100; ≥60% = adenoma and is the primary metric when an unenhanced phase is available. Relative washout (RPW) = (enhanced − delayed) / enhanced × 100; ≥40% is a supportive criterion, most useful when no unenhanced phase was obtained. Unenhanced ≤10 HU alone indicates a lipid-rich adenoma (washout unnecessary). Apply only to homogeneous masses; do not use when pheochromocytoma, hypervascular metastasis, or adrenocortical carcinoma is suspected.

Source: Adrenal washout CT — Caoili EM et al. Radiology (2002); Incidental adrenal mass — Mayo-Smith WW et al. J Am Coll Radiol (2017)

Used in: Adrenal incidentaloma — CT / MRI

ASPECTS

Alberta Stroke Program Early CT Score

10-point topographic score for early ischemic change in the MCA territory on non-contrast CT. Start at 10 and subtract 1 for each involved region.

Regions with early ischemic change (subtract 1 each)
ASPECTS 10No early ischemic change in the MCA territory.

No CT evidence of established infarction. Correlate with CTA/CT perfusion and time from onset.

Non-contrast CT: ASPECTS 10. No CT evidence of established infarction. Correlate with CTA/CT perfusion and time from onset.

Source: ASPECTS — Barber PA et al. Lancet (2000)

Used in: Acute ischemic stroke — CT (ASPECTS)

Bosniak classification

Bosniak version 2019 (CT/MRI)

Classification of a cystic renal mass on contrast-enhanced CT or MRI.

Enhancing nodule
Wall and septa
Number of septa
Calcification

Complete the inputs to see the result.

Source: Bosniak Classification version 2019 — Silverman SG et al. Radiology (2019)

Used in: Cystic renal mass — CT / MRI (Bosniak)

CAD-RADS 2.0

CAD-RADS 2.0 (2022)

Coronary artery disease category from coronary CT angiography, by the highest-grade luminal stenosis.

Extent of severe (70–99%) disease
Left main stenosis ≥ 50%

Complete the inputs to see the result.

Source: CAD-RADS 2.0 — Cury RC et al. J Cardiovasc Comput Tomogr / Radiology: Cardiothoracic Imaging (2022)

Used in: Coronary CTA — CAD-RADS 2.0

Carotid US velocity criteria

SRU consensus 2003

Doppler estimate of ICA stenosis from peak systolic velocity.

Complete the inputs to see the result.

Source: Carotid US consensus — Grant EG et al. Radiology (SRU) (2003)

Used in: Carotid stenosis — US / CTA (NASCET)

CT hepatic steatosis

Liver fat estimate from unenhanced CT attenuation.

Complete the inputs to see the result.

Applies to UNENHANCED CT only. Liver − spleen ≤ −10 HU, or absolute liver attenuation < 40 HU, indicates moderate–severe steatosis. Contrast-enhanced attenuation is unreliable.

Source: CT quantification of liver fat — Kodama Y et al. AJR (2007)

Used in: Hepatic steatosis — US / CT / MRI

Doppler resistive index (RI)

Resistive index from peak systolic and end-diastolic velocities.

Complete the inputs to see the result.

RI = (PSV − EDV) / PSV. Typical adult renal/parenchymal RI ≈ 0.5–0.7.

Source: Doppler resistive index — Tublin ME et al. AJR (2003)

Standalone calculator

Ellipsoid volume

Volume of an ellipsoid lesion or organ from three orthogonal diameters.

Complete the inputs to see the result.

Ellipsoid formula V = (π/6) × L × W × H. 1 cm³ = 1 mL.

General prolate-ellipsoid volume formula; no single clinical source.

Used in: Thyroid nodule — Ultrasound (ACR TI-RADS), Incidental pulmonary nodule — CT (Fleischner), Cystic renal mass — CT / MRI (Bosniak), Solid renal mass — CT / MRI, Adnexal lesion — Ultrasound (O-RADS), Lung cancer screening — CT (Lung-RADS), Splenomegaly — CT / MRI / US, Adnexal lesion — MRI (O-RADS MRI)

Fleischner Society recommendation

Fleischner Society 2017

Incidental pulmonary nodule follow-up. Applies to patients ≥35 years; not for lung-cancer screening, immunocompromised patients, or those with known primary cancer.

Nodule type
Number
Patient risk
Size

Complete the inputs to see the result.

Source: Fleischner Society 2017 guidelines — MacMahon H et al. Radiology (2017)

Used in: Incidental pulmonary nodule — CT (Fleischner)

Gallbladder polyp management

SRU consensus 2022 (Kamaya et al.)

Management of an incidentally detected gallbladder polyp on ultrasound, stratified by morphology and size. Does not apply to primary sclerosing cholangitis (refer to GI guidelines).

Morphology (risk category)
Size

Complete the inputs to see the result.

Source: SRU gallbladder polyp consensus — Kamaya A et al. Radiology (2022)

Used in: Gallbladder polyp — Ultrasound (SRU 2022)

Gestational age from CRL

Gestational age from crown–rump length (Robinson–Fleming).

Complete the inputs to see the result.

Robinson–Fleming: GA (days) = 8.052 × √(1.037 × CRL) + 23.73, with CRL in mm. Most accurate in the first trimester (CRL ≈ 7–84 mm); CRL dating is preferred over LMP when they differ by more than the accepted margin.

Source: CRL dating — Robinson HP, Fleming JEE. Br J Obstet Gynaecol (1975)

Used in: Early pregnancy dating — Ultrasound

Gestational age from MSD

Gestational age from mean sac diameter (before an embryo is visible).

Complete the inputs to see the result.

GA (days) ≈ mean sac diameter (mm) + 30. Use only before a measurable embryo appears; once a CRL is available, date by CRL. MSD alone should not be used to diagnose pregnancy failure.

Source: Gestational sac dating — Hellman LM et al. / ISUOG guidance (1969)

Used in: Early pregnancy dating — Ultrasound

LI-RADS diagnostic category

ACR LI-RADS v2018 (CT/MRI)

Diagnostic category for an untreated liver observation in a patient at high risk for HCC (cirrhosis, chronic hepatitis B, or prior HCC).

Arterial phase hyperenhancement (APHE)
Nonperipheral washout
Enhancing capsule
Threshold growth (≥50% in ≤6 months)

Complete the inputs to see the result.

Source: CT/MRI LI-RADS v2018 — American College of Radiology (2018)

Used in: Liver observation — CT / MRI (LI-RADS)

Lung-RADS

ACR Lung-RADS v2022

Category and management for a screen-detected pulmonary nodule on low-dose CT lung cancer screening.

Finding
Timing
Additional suspicious features (→ 4X)

Complete the inputs to see the result.

Source: ACR Lung-RADS v2022 — American College of Radiology / Christensen J et al. (2022)

Used in: Lung cancer screening — CT (Lung-RADS)

Modified CT severity index

Modified CTSI (Mortele 2004)

Severity of acute pancreatitis on contrast-enhanced CT.

Pancreatic inflammation
Pancreatic necrosis
Extrapancreatic complications

Complete the inputs to see the result.

Source: Modified CT severity index — Mortele KJ et al. AJR (2004)

Used in: Acute pancreatitis — CT (modified CTSI)

MRI fat fraction (two-point Dixon)

Estimated hepatic fat fraction from in-phase and opposed-phase signal.

Complete the inputs to see the result.

Two-point Dixon estimate: FF = (IP − OP) / (2 × IP) × 100. Confounded by iron and valid only up to ~50% fat. Dedicated PDFF sequences are preferred; thresholds are approximate.

Source: Quantitative MRI of hepatic fat (PDFF) — Reeder SB et al. J Magn Reson Imaging (2011)

Used in: Hepatic steatosis — US / CT / MRI

NASCET carotid stenosis

Percent internal carotid stenosis by the NASCET method (from CTA/MRA/DSA).

Complete the inputs to see the result.

NASCET % = (1 − narrowest ICA lumen / normal distal ICA lumen) × 100. In near-occlusion the distal ICA collapses, invalidating the ratio — report as 'near-occlusion' rather than a percentage.

Source: NASCET — North American Symptomatic Carotid Endarterectomy Trial. NEJM (1991)

Used in: Carotid stenosis — US / CTA (NASCET)

O-RADS MRI score

ACR O-RADS MRI (2020/2022)

Risk stratification of an adnexal lesion on MRI (ADNEX MR / O-RADS MRI). Solid-tissue lesions are scored by the dynamic contrast-enhanced time-intensity curve relative to the outer myometrium.

Peritoneal / omental / mesenteric nodularity or irregular thickening
Complex unilocular cyst — menopausal status & size

Complete the inputs to see the result.

Source: O-RADS MRI risk stratification system — Sadowski EA, Thomassin-Naggara I et al. Radiology (2022); Reporting adnexal lesions with O-RADS MRI — Sadowski EA et al. RadioGraphics (2022)

Used in: Adnexal lesion — MRI (O-RADS MRI)

O-RADS US risk category

ACR O-RADS US v2022

Risk stratification of an adnexal lesion on ultrasound.

Color score (vascularity)
Papillary projections (unilocular cyst with solid)
Acoustic shadowing (smooth solid lesion)
Ascites or peritoneal nodules

Complete the inputs to see the result.

Source: O-RADS US v2022 update — Strachowski LM et al. Radiology (2023)

Used in: Adnexal lesion — Ultrasound (O-RADS)

Percentage volume / size change

Percentage change between a prior and current measurement.

Complete the inputs to see the result.

Percentage change = (current − prior) / prior × 100. Use consistent units (diameter or volume).

General arithmetic (percentage change); no clinical source.

Used in: Incidental pulmonary nodule — CT (Fleischner), Abdominal aortic aneurysm — US / CT, Lung cancer screening — CT (Lung-RADS)

Prostate volume

Prostate volume from three orthogonal diameters (ellipsoid method).

Complete the inputs to see the result.

Ellipsoid formula V = (π/6) × L × W × H. 1 mL ≈ 1 g of prostate tissue.

General prolate-ellipsoid volume formula; no single clinical source.

Used in: Prostate — MRI (PI-RADS, PSA density)

PSA density

Serum PSA divided by prostate volume.

Complete the inputs to see the result.

PSA density = serum PSA ÷ prostate volume. A threshold of ≥0.15 ng/mL/cc is commonly used but is not universal.

Source: PSA density — Benson MC et al. J Urol (1992)

Used in: Prostate — MRI (PI-RADS, PSA density)

RENAL nephrometry score

RENAL nephrometry (Kutikov & Uzzo 2009)

Anatomic complexity of a solid renal mass for surgical planning.

(R) Radius — maximal diameter
(E) Exophytic / endophytic
(N) Nearness to collecting system / sinus
(L) Location relative to polar lines

Complete the inputs to see the result.

Source: RENAL nephrometry score — Kutikov A, Uzzo RG. J Urol (2009)

Used in: Solid renal mass — CT / MRI

Splenic index & volume

Splenic index and estimated volume from three orthogonal dimensions.

Complete the inputs to see the result.

Splenic index = length × width × thickness (cm); normal ≈ 120–480 cm³. Estimated volume = 0.524 × L × W × Th. A craniocaudal length > 13 cm on ultrasound also indicates splenomegaly. Use pediatric-specific references under 18 years.

Source: Splenic index — Prassopoulos P et al. Eur Radiol (1997)

Used in: Splenomegaly — CT / MRI / US

Thyroid volume

Total thyroid volume from per-lobe dimensions (ellipsoid method).

Complete the inputs to see the result.

Lobe volume = 0.529 × length × width × depth (isthmus excluded). Normal upper limit ≈18 mL (women), ≈25 mL (men).

Source: Thyroid volume by US — Shabana W et al. AJR (2006)

Used in: Thyroid nodule — Ultrasound (ACR TI-RADS)